Innogen  ·  Publications  ·  Briefings
Appropriate Governance of the Life Sciences (06)
Where are Product Development Partnerships (PDPs) headed and how can Technologies for Health Systems Strengthening (THeSyS) help them get there?

The last decade has witnessed a flourishing of new approaches to financing and addressing neglected diseases including Product Development Partnerships (PDPs). Many PDPs have taken root with funding by the Rockefeller and Gates Foundations, some bi-lateral funding agencies and a range of other public and private donors. Most are not-for-profit. They use public private partnerships arrangements to develop new drugs and vaccines for neglected diseases.